← All companies

TEVJ

Teva Pharmaceutical Industries Limited

TEVJF NYSE Pharmaceutical Preparations EDGAR ↗

$28.40

+0.00 0.00%

Key statistics

from XBRL data in SEC filings

Market cap

$33.1B

Revenue (TTM)

$14.1B

Net income (TTM)

$707M

EPS (TTM)

$0.61

P/E ratio

46.6

Dividend yield

—

Free cash flow

$1.35B

Cash

$3.65B

Total assets

$39.9B

Gross margin

64.4%

52-week range

$14.00 – $37.00

Recent SEC filings

40 most recent

Annual, quarterly & current reports

10-Q Quarter ended 2026-06-30 Jul 29, 2026 8-K Results of operations (earnings release) Jul 29, 2026 8-K Shareholder vote results May 28, 2026 10-Q Quarter ended 2026-03-31 Apr 29, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Apr 29, 2026 10-K Fiscal year ended 2025-12-31 Feb 3, 2026 8-K Results of operations (earnings release) Jan 28, 2026 8-K Results of operations (earnings release) Jan 12, 2026 8-K Entered a material agreement; Took on a direct financial obligation Dec 11, 2025 10-Q Quarter ended 2025-09-30 Nov 5, 2025 8-K Results of operations (earnings release) Nov 5, 2025 10-Q Quarter ended 2025-06-30 Jul 30, 2025 8-K Results of operations (earnings release) Jul 30, 2025 8-K Shareholder vote results Jun 5, 2025 8-K Entered a material agreement; Took on a direct financial obligation May 28, 2025 8-K Regulation FD disclosure; Other events May 22, 2025 10-Q Quarter ended 2025-03-31 May 7, 2025 8-K Results of operations (earnings release) May 7, 2025 10-K Fiscal year ended 2024-12-31 Feb 5, 2025 8-K Results of operations (earnings release) Jan 29, 2025 8-K Director or officer change Nov 12, 2024 10-Q Quarter ended 2024-09-30 Nov 6, 2024 8-K Results of operations (earnings release) Nov 6, 2024 10-Q Quarter ended 2024-06-30 Jul 31, 2024 8-K Results of operations (earnings release) Jul 31, 2024 8-K Entered a material agreement Jun 25, 2024 8-K Shareholder vote results Jun 6, 2024 8-K Director or officer change; Regulation FD disclosure May 15, 2024 10-Q Quarter ended 2024-03-31 May 8, 2024 8-K Results of operations (earnings release) May 8, 2024 8-K Regulation FD disclosure Apr 18, 2024 10-K Fiscal year ended 2023-12-31 Feb 12, 2024 8-K Results of operations (earnings release) Jan 31, 2024 10-Q Quarter ended 2023-09-30 Nov 9, 2023 8-K Results of operations (earnings release) Nov 8, 2023 8-K Regulation FD disclosure Oct 4, 2023 8-K Director or officer change; Regulation FD disclosure Sep 28, 2023 8-K Entered a material agreement; Regulation FD disclosure Aug 24, 2023 8-K Director or officer change Aug 2, 2023 10-Q Quarter ended 2023-06-30 Aug 2, 2023